Bio-Rad Laboratories, Inc. 8-K Summary
Business Context and Reporting Period
This Form 8-K reports the results of the Annual Meeting of Stockholders held by Bio-Rad Laboratories, Inc. on April 25, 2017. The filing details the outcomes of six specific proposals submitted to security holders for a vote.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and voting results rather than financial performance.
Material Changes and Voting Results
The following matters were voted upon and approved by stockholders:
- Election of Directors: All nominated directors were elected. Class A directors (Melinda Litherland, Arnold A. Pinkston) received over 19.9 million votes each. Class B directors (Jeffrey L. Edwards, Gregory K. Hinckley, Alice N. Schwartz, Norman Schwartz) received between 4.92 million and 4.93 million votes each.
- Auditor Ratification: The selection of KPMG LLP as independent auditors for the fiscal year ending December 31, 2017, was ratified with 7,279,650 votes in favor.
- 2017 Incentive Award Plan: Approved with 6,030,772 votes in favor and 927,471 votes against.
- Employee Stock Purchase Plan Amendment: An amendment to increase authorized shares by 700,000 was approved with 6,958,695 votes in favor.
- Executive Compensation (Say-on-Pay): The non-binding advisory vote was approved with 6,894,740 votes in favor.
- Frequency of Say-on-Pay Votes: Stockholders voted to hold future advisory votes on executive compensation every three years (5,806,177 votes for 3 years).
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document confirms the company will adhere to the three-year frequency for executive compensation votes as determined by the Board and stockholders.
Investor Verification Checklist
- Verify the total number of shares outstanding to contextualize the voting percentages.
- Review the specific terms of the 2017 Incentive Award Plan approved by stockholders.
- Confirm the details of the 700,000 share increase in the Employee Stock Purchase Plan.
- Check subsequent filings for the company's financial results for the fiscal year ending December 31, 2017, as audited by KPMG.